Skip to main content
. 2020 Nov 19;8:583206. doi: 10.3389/fped.2020.583206

Table 6.

The distribution of samples in the three study regions depending on prophylactic doses of cholecalciferol.

Doses of cholecalciferol, IU Studies numbers in Moscow, n (%) Studies numbers in Krasnoyarsk, n (%) Studies numbers in Stavropol, n (%) Total, n (%)
0 90 (59.6) 65 (47.4) 51 (32.9) 206 (46.4)
1–1,000 53 (35.1) 47 (34.3) 49 (31.0) 149 (33.4)
1,001–1,500 0 (0%) 16 (11.7) 45 (28.5) 61 (13.7)
≥1,500 8 (5.3) 9 (6.6) 12 (7.6) 29 (6.5)